New Treatments & Clinical Trials for Anxiety Disorders

Anxiety disorders affect about 30% of adults at some point in life. Current treatment centers on SSRIs, SNRIs, and therapy like cognitive behavioral therapy. Most people improve with these approaches, but some don't respond fully or tolerate medication side effects poorly.

What's actually going on in research

Trials are testing fast-acting drugs that work differently from SSRIs, psychedelics paired with therapy for treatment-resistant cases, digital therapeutics including VR exposure therapy, and new approaches to social anxiety and panic disorder. Researchers are also studying biomarkers that might predict which treatment will work for whom.

What to know before you search

Eligibility typically depends on anxiety severity, specific diagnosis (generalized anxiety, social anxiety, panic disorder), whether prior treatments have been tried, and whether other mental health conditions are present.

What types of trials are currently open

• Medication trials — Testing new drugs or new uses of existing drugs, often comparing them to SSRIs or placebo. Many focus on people who haven't improved with standard medications.
• Therapy trials — Comparing different forms of psychotherapy or testing whether therapy works as well when delivered digitally as in person.
• Combination trials — Testing whether pairing a medication with therapy works better than either alone, or whether adding a second drug helps when one drug isn't enough.
• Device trials — Studies of brain stimulation devices, VR exposure systems, and wearable biofeedback tools designed to reduce anxiety symptoms.
• Biomarker studies — Collecting genetic, brain imaging, or other biological data to understand why some people respond to treatment and others don't.